Ipilimumab/nivolumabBullous pemphigoid: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1769卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67274-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：260 / 260

相关论文

共 50 条

[41] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2024, 2028 (1) : 253 - 253
[42] Ipilimumab/sargramostimDermatomyositis: case report
Reactions Weekly, 2016, 1603 (1) : 158 - 158
[43] Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly, 2019, 1734 (1) : 292 - 292
[44] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1748 (1) : 266 - 266
[45] Ipilimumab/nivolumabVitiligo: case report
Reactions Weekly, 2019, 1769 (1) : 262 - 262
[46] Ipilimumab/pembrolizumabHypophysitis: case report
Reactions Weekly, 2022, 1909 (1) : 306 - 306
[47] Ipilimumab/nivolumabHypopituitarism : case report
Reactions Weekly, 2022, 1907 (1) : 267 - 267
[48] Ipilimumab/nivolumabPancytopenia: case report
Reactions Weekly, 2024, 2023 (1) : 212 - 212
[49] Ipilimumab/nivolumabColitis: case report
Reactions Weekly, 2023, 1942 (1) : 157 - 157
[50] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1747 (1) : 159 - 159

← 1 2 3 4 5 →